Navigation Links
Enerkem Announces Construction Start of World's First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
Date:8/31/2010

EDMONTON, Aug. 31 /PRNewswire/ - Enerkem Inc., a leading waste-to-biofuels company, today held a groundbreaking ceremony to signify the start of construction of its municipal waste-to-biofuels facility with its partners, the City of Edmonton and the Government of Alberta. Alberta Premier Ed Stelmach, Edmonton Mayor Stephen Mandel and Enerkem Chief Executive Officer Vincent Chornet participated in the event.

Enerkem's advanced biofuels plant, which will be located in Edmonton, Alberta, is the world's first industrial-scale biofuels project to use municipal solid waste as feedstock. It will have an annual production capacity of 36 million litres/10 million gallons. Using Enerkem's proprietary clean technology, the CAD$ 80 million facility will produce enough biofuels to fuel over 400,000 cars per year running on a five per cent ethanol blend. It will be built, owned and operated by Enerkem Alberta Biofuels LP, a wholly-owned subsidiary of Enerkem. The City of Edmonton and Enerkem Alberta Biofuels have signed a 25-year agreement to convert 100,000 tonnes of the City's municipal solid waste into biofuels annually. The garbage to be used cannot be recycled or composted.

"This groundbreaking marks the launch of a transformative project and leads the first wave of commercial-scale advanced biofuels plants in North America", said Enerkem's President and Chief Executive Officer, Vincent Chornet. "This plant is the genesis of a world transformation where our non-recyclable garbage will power the vehicles we drive and reduce carbon emissions."

"Alberta is an energy province," said Premier Ed Stelmach. "This project is another example of how our government is helping develop leading-edge renewable and non-renewable energy technology. I applaud the vision and dedication the partners have shown to make this pioneering project a reality."

"Edmonton's environmental leadership has us continually looking to set the bar higher," said Edmonton Mayor, Step
'/>"/>

SOURCE Enerkem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Enerkem appoints new Chief Financial Officer
2. Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project
3. Enerkem Named an Emerging Cleantech Leader in Canada
4. Enerkem Announces Unique Community Energy Project
5. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
6. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
7. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
8. Enerkem announces plans to enter the United States with next-generation biofuels project in Mississippi
9. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
10. Enerkem Expands Executive Management Team
11. MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 21, 2014 Shimadzu Scientific Instruments introduces ... tool for the pain management and clinical markets. The ... and review by allowing users to highlight and review ... , QuantAnalytics allows analysts to filter results by group ... processing by eliminating the need to sift through analytes ...
(Date:10/22/2014)... 2014 Grace Century, a private equity ... announces the addition of Dr. Yousef “Josh” Siddiqui ... team. Dr. Siddiqui will provide further healthcare expertise to ... of University College Medical School in the ... in 2001. With further certification as a General Practitioner ...
(Date:10/22/2014)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... its Oral Amphotericin B program.  The company recently ... work involving samples from HIV/AIDS patients exposed ... pre clinical studies and regulatory filings to move ... utilizing approximately $700,000 of funding and technological advice ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... Sciences,Holdings, Inc. (Nasdaq: ADLS ) a biopharmaceutical company ... in the,therapeutic areas of infection, cancer and respiratory diseases, ... Bank to increase,its line of credit from $4 million ... by 12 months to January 1, 2011. The closing ...
... Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) today announced ... Oncolytic Reovirus (REOLYSIN(R)) in Combination with,Carboplatin/Paclitaxel in ... in the November/December issue of the Journal ... Society for Biological Therapy of,Cancer (iSBTc). The ...
... 23 Schering-Plough,Corporation (NYSE: SGP ) ... has met the primary endpoint in a ... administered as a,fast-dissolving sublingual tablet, is a ... The study was a randomized, placebo-controlled, ...
Cached Biology Technology:Advanced Life Sciences Completes Debt Transaction 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting 3Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial 2
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
(Date:10/15/2014)... Johannes Gutenberg University Mainz (JGU) as a full ... to maintain a significant nationwide standing in the ... of Johannes Gutenberg University Mainz as a full ... the national and international competition for the best ... can be proud that Mainz University has been ...
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
... light on the multi-decade debate about how the brain knows where ... watch your legs and feet when you walk. Your brain knows ... how the brain achieves this: , (1) the outflow hypothesis says ... them how strongly to contract, and uses this to predict where ...
... shows there's a constant shuffling of genetic endowments going ... seems to be a flood of viruses, MIT scientists ... W. Chisholm, is uncovering a challenging new facet of ... exploit changing conditions such as altered light, temperature and ...
... the brain enhances long-term storage of fearful memories ... of Medicine researchers report this week in Nature ... demonstrate evidence of enhancements in memory reconsolidation in ... associate professor in the Department of Psychiatry. "Understanding ...
Cached Biology News:How does the brain know what the right hand is doing? 2MIT: Oceans are a major gene swap-meet for plankton 2MIT: Oceans are a major gene swap-meet for plankton 3MIT: Oceans are a major gene swap-meet for plankton 4Activation of a protein solidifies fear memory in the brain 2
...
... glycerol stocks contained in standard 96-well microtiter ... with approximately 5,000 clones per plate. After ... well, the corresponding subplate is screened with ... positive well(s). Cells from a positive well ...
... benchmark for analytical performance ... and the ultimate in analytical,performance, ... Varian 810-MS features include: , ... minimize,interferences, providing reliable, routine, trace ...
... A full-featured high-performance ICP-MS system designed ... sampling interface, Omega II off-axis ion lens, ... the 7500a can handle the widest range ... 2003, the 7500a now includes as standard ...
Biology Products: